Sorrento Therapeutics, Inc. announced that Robin L. Smith, MD, MBA has been appointed to its Board of Directors. Dr. Smith is a business leader, entrepreneur, medical doctor, author and philanthropist who has held various C-Suite and board positions in the biopharmaceutical industry. Her experience includes significant contributions on numerous board committees for public medical, digital and health care entities. She currently serves on the boards of directors of Celularity, Inc.